Changes in the microbiome architecture and bile acids, improved insulin sensitivity and restored β-cell mass and function mediated by incretins, including the glucagon like peptide (GLP1), collectively account for instances of T2D remission after bariatric surgery6. This evidence concerns the gene GCG and type 2 diabetes mellitus.